Eyenovia, Inc. (EYEN) Dividend History

Company News

• Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

  The retinal and fundus camera market is experiencing growth driven by the evolving landscape of imaging technologies, particularly in diagnosing age-related macular degeneration (AMD). The integration of artificial intelligence (AI) into fundus cameras presents a significant opportunity for market growth, with AI algorithms demonstrating high accuracy in detecting diseases like diabetic retinopathy (DR).

  GlobeNewswire Inc.

  Featured Companies: BLCO BMEA OTLK
• Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

  Eyenovia, Inc. has announced an amendment to its senior secured convertible debt, deferring interest and principal payments through September 2025. This provides financial flexibility as the company evaluates strategic alternatives to maximize shareholder value.

  GlobeNewswire Inc.
• Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

  Eyenovia, an ophthalmic technology company, announced that leading proxy advisory firms ISS and Glass Lewis have recommended that Eyenovia stockholders vote in favor of a proposed reverse stock split at the upcoming special meeting. The reverse stock split is intended to enable Eyenovia to regain compliance with Nasdaq's Minimum Bid Price Requirement and maintain its Nasdaq listing.

  GlobeNewswire Inc.
• Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block

  TD Bank is considering selling its 10.1% stake in Charles Schwab as part of a strategic review. Eyenovia hired an investment bank to explore a reverse merger or sale, while Smart Share Global and Modernizing Medicine are also considering buyout offers. Several companies, including true Religion and Calpine, have been involved in mergers and acquisitions.

  Benzinga

  Featured Companies: CEG DIS FUBO GT KKR PAYX TD
• Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

  Eyenovia, an ophthalmic technology company, has engaged Chardan as its financial advisor to evaluate strategic alternatives, including a potential business combination, sale, or reverse merger. The company continues to progress the development of its Optejet device, exploring options for both consumer and drug-device combination products.

  GlobeNewswire Inc.